Nisa Investment Advisors LLC Acquires 3,370 Shares of Intuitive Surgical, Inc. $ISRG

Nisa Investment Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,861 shares of the medical equipment provider’s stock after buying an additional 3,370 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Intuitive Surgical were worth $62,221,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Rakuten Investment Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at about $388,436,000. Assenagon Asset Management S.A. boosted its stake in Intuitive Surgical by 106.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after purchasing an additional 791,516 shares during the last quarter. Amundi increased its holdings in Intuitive Surgical by 29.7% during the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after purchasing an additional 739,444 shares in the last quarter. Sands Capital Management LLC increased its holdings in Intuitive Surgical by 77.0% during the 3rd quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock worth $599,784,000 after purchasing an additional 583,539 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in shares of Intuitive Surgical by 41.3% in the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock worth $868,212,000 after purchasing an additional 567,483 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 1.8%

Shares of NASDAQ ISRG opened at $460.99 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The stock’s 50 day moving average price is $491.53 and its 200-day moving average price is $513.74. The company has a market capitalization of $163.71 billion, a PE ratio of 58.43, a PEG ratio of 3.49 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.21 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ISRG shares. The Goldman Sachs Group restated a “buy” rating and issued a $714.00 target price on shares of Intuitive Surgical in a report on Friday, January 9th. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday. Wells Fargo & Company increased their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Robert W. Baird dropped their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. The trade was a 50.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst/technical optimism: Commentary noting ISRG is technically oversold and that Wall Street estimate revisions are tilting upward is supporting a near-term bounce and buy-the-dip demand. Down 10.1% in 4 Weeks, Here’s Why Intuitive Surgical (ISRG) Looks Ripe for a Turnaround
• Positive Sentiment: Fundamentals remain supportive: Intuitive posted an EPS and revenue beat in its latest quarter with healthy margins and double‑digit revenue growth year-over-year — this gives investors confidence that demand for robot-assisted procedures and consumables can reaccelerate. (See company reports and recent earnings commentary.)
• Neutral Sentiment: Market recap: Recent news pieces note ISRG rose but still lagged the broader market on the session, reflecting mixed investor appetite versus larger-cap growth peers. Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
• Neutral Sentiment: Sector/peer headlines may influence sentiment: Big moves in med‑tech peers (large drawdowns at some names and product launches at others) are creating rotation and headline-driven volatility that can impact ISRG. Examples include coverage of Boston Scientific’s selloff and Baxter’s new IV labeling system. Can Boston Scientific Stock Surge 40% From Here? Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy
• Negative Sentiment: Technical and momentum concerns remain: ISRG has been through a recent pullback (50‑day moving average below the 200‑day) and a multi-week decline that could keep downside risk elevated if procedure volumes or guidance disappoint. Investors should watch upcoming volumes, guidance, and margin commentary closely.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.